BCA蛋白濃度測(cè)定試劑盒(增強(qiáng)型)_第1頁(yè)
BCA蛋白濃度測(cè)定試劑盒(增強(qiáng)型)_第2頁(yè)
BCA蛋白濃度測(cè)定試劑盒(增強(qiáng)型)_第3頁(yè)
BCA蛋白濃度測(cè)定試劑盒(增強(qiáng)型)_第4頁(yè)
BCA蛋白濃度測(cè)定試劑盒(增強(qiáng)型)_第5頁(yè)
已閱讀5頁(yè),還剩21頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

BCA蛋白濃測(cè)定試劑盒增強(qiáng)型BCA白濃度測(cè)定試劑盒(增強(qiáng)型)BCA白濃度測(cè)定試劑盒(增強(qiáng)型)產(chǎn)品編號(hào)產(chǎn)品名稱(chēng)包裝蛋白濃度測(cè)定試劑盒(增強(qiáng)型次產(chǎn)品簡(jiǎn)介:BCA白濃度測(cè)定試劑盒(增強(qiáng)型)(EnhancedBCAProteinKit)是根據(jù)目前世界上最常用的兩種蛋白濃度檢測(cè)方法之一BCA法制而成,實(shí)現(xiàn)了蛋白濃度測(cè)定的簡(jiǎn)單,高穩(wěn)定性,高靈敏度和高兼容性。和碧云天生產(chǎn)的普通白濃度測(cè)定試劑盒相比,靈敏度更高,檢測(cè)濃度下限達(dá)到10g/ml,最小檢測(cè)蛋白量達(dá)到,待測(cè)樣品體積為1-20l和碧云天生產(chǎn)的普通白濃度測(cè)定試劑盒相比,顯色速度更快,相同的樣品孵育較短時(shí)間即可進(jìn)行吸光度測(cè)定。在20-1000g/ml濃度范圍內(nèi)有較好的線性關(guān)系。測(cè)定蛋白濃度不受絕大部分樣品中的化學(xué)物質(zhì)的影響,可以兼容樣品中高達(dá)的,的X-100,的80但受螯合劑和略高濃度的還原劑的影響,需確保低10mM無(wú),二硫蘇糖醇低于,β-巰基乙醇低于0.01%。不適用BCA法建議試用碧云天生產(chǎn)的Bradford白濃度測(cè)定試劑盒(P0006)BCA白濃度測(cè)定試劑盒(增強(qiáng)型)對(duì)樣品中各種物質(zhì)的詳細(xì)的兼容性和普通的白濃度測(cè)定試劑盒相同,請(qǐng)參考碧云天如下網(wǎng)頁(yè):

ForKit.pdf每個(gè)試劑盒可以檢測(cè)5000樣品。包裝清單:產(chǎn)品編號(hào)產(chǎn)品名稱(chēng)包裝試劑瓶,共P0009-2劑P0009-3蛋白標(biāo)準(zhǔn)管,共2管P0009-4蛋白標(biāo)準(zhǔn)配制液―說(shuō)明書(shū)保存條件:室溫保存。蛋白標(biāo)準(zhǔn)配制成溶液后凍存。注意事項(xiàng):需酶標(biāo)儀一臺(tái),測(cè)定波長(zhǎng)為540-595nm之間,最佳。需96孔板。如果沒(méi)有酶標(biāo)儀,也可以使用普通的分光光度計(jì)測(cè)定,但測(cè)定時(shí),需根據(jù)比色皿的最小檢測(cè)體積,適當(dāng)加大作液的用量使不小于最小檢測(cè)體積,樣品和標(biāo)準(zhǔn)品的用量可相應(yīng)按比例放大也可不變。使用分光光度計(jì)測(cè)定蛋白濃度時(shí),每個(gè)試劑盒可以測(cè)定的樣品數(shù)量可能會(huì)顯著減少。如發(fā)現(xiàn)樣品稀釋液或裂解液本身就有較高背景,請(qǐng)?jiān)囉帽淘铺焐a(chǎn)的Bradford蛋白濃度測(cè)定試劑盒(P0006)。為了加快測(cè)定蛋白濃度的速度可以適當(dāng)用微波爐加熱,但是切勿過(guò)熱。度必須小于,不兼容。不適用BCA法時(shí),請(qǐng)?jiān)?/p>

用碧云天生產(chǎn)的Bradford蛋白濃度測(cè)定試劑盒(。為了您的安全和健康,請(qǐng)穿實(shí)驗(yàn)服并戴一次性手套操作。使用說(shuō)明:1.取1.2ml蛋白標(biāo)準(zhǔn)配制液加入到一管蛋白標(biāo)準(zhǔn)(30mg中,充分溶解后配制成蛋白標(biāo)準(zhǔn)溶液。配制后可立即使用,也可以長(zhǎng)期保存。2.取適量25mg/ml蛋白標(biāo)準(zhǔn),稀釋至終濃度為。例如取25mg/ml蛋白標(biāo)準(zhǔn),加入980l稀釋液即可配制成白標(biāo)準(zhǔn)。蛋白樣品在什么溶液中,標(biāo)準(zhǔn)品也宜用什么溶液稀釋。但是為了簡(jiǎn)便起見(jiàn),也可以用0.9%NaCl或稀釋標(biāo)準(zhǔn)品。稀釋后的蛋白標(biāo)準(zhǔn)也可以長(zhǎng)期保存。3.根據(jù)樣品數(shù)量,按50積BCA劑1體積試劑B(50:1)配制適量作液,充分混勻。例如5mlBCA劑A100lBCA試B混勻,配制成BCA工作液。作液室溫24時(shí)內(nèi)穩(wěn)定。4.將標(biāo)準(zhǔn)品按0,4,20l加到96板的標(biāo)準(zhǔn)品孔中,加標(biāo)準(zhǔn)品稀釋液補(bǔ)足到20l5.加適當(dāng)體積樣品到96板的樣品孔中,加標(biāo)準(zhǔn)品稀釋液到20l6.各孔加入作液,37℃置鐘。注:也可以室溫放置2時(shí),或℃置30鐘。測(cè)定蛋白濃度時(shí),顏色會(huì)隨著時(shí)間的延長(zhǎng)不斷加深。并且顯色反BCA白濃度測(cè)定試劑盒(增強(qiáng)型)

應(yīng)會(huì)因溫度升高而加快。如果濃度較低,適合在較高溫度孵育,或適當(dāng)延長(zhǎng)孵育時(shí)間。7.測(cè)定,間的波長(zhǎng)也可接受。根據(jù)標(biāo)準(zhǔn)曲線計(jì)算出樣品的蛋白濃度。常見(jiàn)問(wèn)題:1.測(cè)定標(biāo)準(zhǔn)曲線時(shí)發(fā)現(xiàn)隨著標(biāo)準(zhǔn)品濃度的增加吸光度或顏色沒(méi)有明顯變化??赡艿脑蚴菢悠分泻袊?yán)重干擾測(cè)定蛋白濃度的物質(zhì),詳細(xì)的的兼容性列表請(qǐng)參考碧云天如下網(wǎng)頁(yè):ForBCAKit.pdf2.是否每次測(cè)定時(shí)都需要做標(biāo)準(zhǔn)曲線?建議每次測(cè)定時(shí)都做標(biāo)準(zhǔn)曲線。因?yàn)闇y(cè)定時(shí)顏色會(huì)隨著時(shí)間的延長(zhǎng)不斷加深,并且顯色反應(yīng)的速度和溫度有關(guān),所以除非精確控制顯色反應(yīng)的時(shí)間和溫度,否則如需精確測(cè)定宜每次都做標(biāo)準(zhǔn)曲線。使用本產(chǎn)品的文獻(xiàn):1.WangLiuWuasanearlyintheofinducedwoodfordinIinK562ToxicolPharmacol.2022Jan2.ChenDF,LiuMJ,Dualeffectsofinduceditscombinationwith

BiolBull.2022Jul;27(7):1075-80.3.ZhengJQ,ZhangYP,LiangWQ.proteindeliverybiodegradablealginate-chitosan-poly(lactic-co-glycoliccompositemicrospheres.BiochemBiophysRes年4.R.-C.Wu,Wang,ChenandX.-S.Yue.β2-integrinsmediatenovelofchemoresistanceincycloheximide-inducedU937apoptosis.Cell.Mol.61(16):2071C2082.5.劉軍丁勁采芳李英輝宮衛(wèi)東趙亞豫曉。帶有蛋白轉(zhuǎn)導(dǎo)域的靶向核糖核酸酶對(duì)乙型肝炎病毒復(fù)制的影響。中華肝臟病雜志2022第第頁(yè)。6.Kaninfoamcellsliquidchromatographic-spectrometry.ChinJ202214(20):51-56.7.PY,WangRN.MethylprotodioscininducesarrestandinK562cellshyperpolarizationof年8.WangJuY,RN,Wucellcyclearrestandinhuman

K562withdisruptionofhomeostasis.20229.JinLiu,Cai-FangXue,Ying-HuiLi,Chen,Huang,Zhong-XiangLiu.cantargetedribonucleaseintohepatocytes.ChinJ2022april10.ZhaoY,GuanOverexpressionQMcelldifferentiationmineralizationinBiolBull.2022Aug;28(8):1371-6.11.LF,Wangoflead(Pb2+)reactionsofinvitroculturedrattoToxicolLett.202215;159(1):71-82.oflead(Pb2+)reactionsofinvitroculturedrattoToxicologyLetters年)WanHanJun,WangXiaofan,Kai,ZhouDongXiaoping.oftheOctapeptideRepeatswithinofRecombinantProteinsProteaseafter

IonsandtheBindingAbilityProtein.ChineseVirology.Yichao,ZouRenJianmin,LiuJian,WangXiaoqin.characterofofHelicobacterproteinencapsulatedbySciences.2022年15.WuZQ,M,ChenChiZQ,Liuofkinasesignalingpathwayinregulationuponopioidreceptorsmorphine.Mol年ZC,LiuYZ,Y,ZhuangFY,FanYB,Ijunctionalcommunicationattenuatesthetumorphenotypeofcervicalcarcinomacellsinvitro.年8;242(1):77-87.BCA白濃度測(cè)定試劑盒(增強(qiáng)型)JK,PengChenCY,ZhangLX.DecreaseIIppt1mutantisdependentage.JIntegrPlantBiol.2022年48(12),YY,J,MaxwellBiYY,YuZN,

keyresiduesinC-terminaldomainofMycobacteriumtuberculosisDNAgyrasesubunitNucleicAcidsRes.2022;JK,PengChenCY,ZhangLX.DecreaseIIinIsDependentonLeafAge.JournalPlantBiology.2022年48(12):1409-1414.20.JiG,WangM,LongLiuCH.RegulativeEffectsItsRecipesonCellsMediatedShanghaiChinesemagazine.2022年Jan;Vol.41No.1.21.LiChenYJ,SunShiYX,WangibitionoffromfarreriUVA2InducedofCellsDependingspase23.ChinJ.2022年Vol.42No.2.22.WuZQ,ChenJ,ZQ,LiuofdopaminesysteminregulationintheuponopioidreceptorsbyMolPharmacol.Yi,Wang,BingXia.Downregulationofconnexininnasopharyngealcellsis

topromotermethylation.2022年Feb14;J,ZhaoJiangInvestigationofAsymptomaticInfectionofEchovirusinPopulationofJournalvirus.2022年25.LF,WangHanYS.Directlead(Pb2+)onrelaxationofinculturedToxicolLett.2022Apr25;170(2):104-10.26.DengChenLL,NX.expressionoffattyliverdiseasebyhigh-fatdietinrats.Int.Jun;27(5):708-15.SB,ChenXH,WangmechanismsofpolypeptidefarreriprotectingcellsfrominducedUVAplusPharmacolSin.年Jul;28(7):1007-14.28.DongS,WuTsienJZ,Y.Environmentenrichmentrescuesneurodegenerativeinmice.EurJNeurosci.年Jul;26(1):101-12.

Q,C,ChenfromarmigeraproteinthatactivatesArp2/3-inducedactinfilamentformation.VirusRes.Jul;127(1):81-7.RenG,Liuj.StudyofmicrospherestechnologyofHelicobacterpyloriwholecellproteinencapsulatedbychitosan2alginate.July;Vol.36No.13.31.LiLiuChenSunM,WangInhibitionapoptoticsignalingpathwaybyfromChlamysfarreriinHaCaTkeratinocytes.Environ年Aug;46(3):263-8.32.YuanP,GaoDengL,ChenP,SunZL,NeuroprotectiveeffectsofRb1transientcerebralinrats.Res.2022SepYR,NieJiangShiZ,R,ZhangLiYJ.DecreaseinnitroglycerinofEurJPharmacol.年24;571(1):44-50.

ZC,WangZhangB.Downregulationofconnexininnasopharyngealcellsistopromotermethylation.2022年Oct;43(9):898-904.JL,WangroleoftumornecrosistedingligandPolypeptidefromChlamysfarreriinapoptosisinChinesePharmulletin.2022年9.Y,DX,WangCharacteristicstifloxaciniverMCytochromeinRats.PharmJ年Dec;Vol.23DingDX,SQ.analysisofenterotoxinMBCA白濃度測(cè)定試劑盒(增強(qiáng)型)ExprPurif.2022Dec;56(2):286-92.Hong,PeijunHanwenDong,SideCovalentbindingof-chymotrypsinonthenanogelsamino

JournalB:年)CY,ZhanginjectionregulationofBcl-2hypoxia/reoxygenationincardiomyocytesinvitro.MolBiol2022年TianDuZY,dietarystatusgrouperEpinepheluscoioides.PhysiolBiochem.(2022年)33:167C172.41.ChengJiangConstructionexpressiongashRNAvectoranditsontionracolorectalcancerlovoJFourth年28(11)。GuoG,XiepreliminaryicalstudyofHelicobacterpyloriine.ChineseDrugs.2022,Vol.16No.7.M,AH,JiHuoxuerecipeanditsseparatedERKsignalinginKupffermediatedLPS.Journal年Vol.17

44.NieH,LiZ,LukasRJ,Y,SongWangM.ConstructionofSH-EP1-alpha4beta2-hAPP695CellandEffectsofNicotinicAgonistsintheMolNeurobiol.ChengY,WangNL,JC,YangYaototalflavonoidsandglycosidesfromontheandosteoblasts.2022BiLJ,ZhangZP,ZhangZhangXE.ofMycobacteriumtuberculosisFEBSJ.2022BaiShiJiangFuGS,AsymmetricinducesTNF-alphaproductionviaROS/NF-kappaBdependentinhumancellsandtheinhibitoryeffectofC.Vascul202248.LiuQ,H,M,YuanQ,Y,ZhuH,M,TangW.

S-adenosylhomocysteineisabetteratherosclerosisthanhomocysteineinapolipoproteinE-deficientfedhighdietarymethionine.J2022年S,GengJ,ZhouP,WangFengX,HuApplicationofahybridorganic-inorganicforefficientacidChimActa.年Mar24;611(2):173-81.ShiJiangChenYR,TangZY,YP,HB,ofpathwayinnitroglycerinroleofLifeSci.年Mar51.S,ZhouP,WangJ,HuJ.hydroxyapatitemonolithicforextractionitsapplicationinpurificationBacillussubtiliscrudelysate.JChromatogr年Mar7;1183(1-2):29-37.52.WangPengKM,SongH,SH,L,JX.1areceptordistributioninovariesofAfricanostrichchicks.年53.LiJ,LiuDingS,Guanoxygenpreconditioninginducestolerancebrain

injurybyofantioxidantenzymesRes.2022MayY,ZhangG,LiuY,J,Hugenetransfertissueinhibitorinvascularsmoothmuscle2022May;13(5):634-40.55.TianB,ZhaoY,WangLiL,LiJ,TianRodriguezR.curcuminonbladdercellsanddevelopmentofurothelialtumorsinrat年Jun18;264(2):299-308.56.YuanPD,LiSB,ZhouDifferentialIL-4/Stat6activitiescorrelatewithdifferentialexpressionofgenesPP2Aincoloncancercells.JCancerClinOncol.2022JunH,NeurotoxicologicalevaluationoflanthanuminToxicolSci.Jun;103(2):354-61.Mar3.BCA白濃度測(cè)定試劑盒(增強(qiáng)型)58.JinGD,LiFJ.Invitrocultivationcellclustersfromhumanumbilical

blood-derivedstemcells.Res.202259.WanYouJ,SunY,CuiDuYZ,YuanH,StudiesSLNsvinorelbinebitartrate(I):preparationevaluationinvitro.IntJ2022年Jul9;359(1-2):104-10.60.TianWangXY,DingGH.Repeatedelectro-acupunctureattenuatesvisceralhypersensitivityspinalinratbowelsyndromeLifeSci.年Jul61.R,LeiY,HanL,P,J,G,ShiJiangW,Y,DongmutantsdifferentnumbersofoctarepeatsequencesareC2022年Jul;51(7):630-9.年JulY,Y,BaiY,Xieadhesionviaactivationofreceptorsincultured2022年Aug;43(2):149-59.63.WeiY,X,YoungJiJ,P.ofJNKstress-mediatedmurine

liverinjuryby2022Aug;13(8):1031-42.64.SL,WangXY,DingGH.Repeatedelectro-acupunctureattenuatesvisceralhypersensitivityspinalinratbowelsyndromeLifeSci.年Aug29;83(9-10):356-63.65.HuZhouZhangH,Gaoofpoly(lactic-co-glycolicacid)microparticles/chitosanhydrogel.JMech年Oct;1(4):352-9.66.ZhuM,F,ShiJ,HuY,Increasedoxidativestressastrogliosisresponsesindouble-knockoutofAlzheimer-likepresenilin-1andFreeRadicBiolNov67.Y,J,LiuX,LiNovelcontrolledtumoringlandsecretionBiochimie.年68.WangYX,XuSuWL,Q,WX,ChenJinLiuYJ,LiRuanCP.ActivationClinicalofMAPKSignalingin

JSurgRes.2022Dec3.69.LiuXiangN,L.cancereffectsofinandpossiblerelationshipArchRes.2022年70.JinD,OjciusDongH,LuoY,YanJ.interrogansincaspase-8-andInfectImmun.2022年Epub202271.LiuXS,J,JiaoWuYE,LinJH,Lycorineanddown-regulationofincells.年8;274(1):16-24.72.ShenWangFunctionalexpressionchannelshumancelllineJUnivSciTechnologSci.年Feb;29(1):64-7.73.LiuX,P,L,Y,PolypeptidefromfarrerimodulatesactivationofNF-kappaBsignalingandprotectioncellsfromapoptosis.

Regul25;153(1-3):49-55.Epub年74.Y,HuM,Y,WangMW.Antioxidativeherbalremedyitsactivehighcells.LifeSci.年Mar75.J,LinY,R,GhrelinprotectsagainstcellinseizuresinNeurosci2022年Mar27;453(1):58-61.76.QiFangS,JinHanX,Y,ZhouH.Carnosineinhibitshighmesangialcellproliferationthroughcellcycleprogression.RegulApr10;154(1-3):69-76.77.LF,Wangaorticcontractileto5-hydroxytryptamineratslead(Pb(2+))exposure.ToxicolLett.2022Apr25;186(2):78-83.BCA白濃度測(cè)定試劑盒(增強(qiáng)型)78.DongWangYZ.Asymmetricsynthesisderivativesascandidates.

BioorgMedChem.2022年May79.X,A,H,Y,J,LiuG.localizationoffactorintheratovarycycleandFertilSteril.2022年May;91(5年80.B,SongJ,ZouY,Q,LeiY,ResponsesvascularsmoothcellsestrogendependentonbalanceERKMAPKpathwayIntJCardiol.年81.YangB,XieinhibitsmonocyticadhesioninducedviadownregulationofreceptorsinEurJClinMay;65(5):457-64.EpubJan22.82.ChenJiangJiTT,Meiincreasedinpresenilin1/presenilin2doublemice.NeurosciBull.2022Jun;25(3):131-7.83.WangXD,T,Q,astilbintaxifolinintheireffectstheP-gp.IntJ2022年Aug13;378(1-2):1-8.

84.B,YangSK,SunZL,YuanChenGJ,K,YuanNeuroprotectiveeffectofGDNFneuralstemcellsischemiainrats.Res.202285.DingD,SunXuePanChenIdentificationofproteincomponentsquantitativeimmunoassayinstaphylococcinJBiomedAnal.2022年15;50(1):79-85.86.LiuX,ShiS,LiuSunM,fromfarreriUVB-inducedactivationandapoptosisinHaCaTcells.JPhotochem年3;96(2):109-16.87.Q,LiP,Y,LiS,ChenA,KongP,OverexpressionInterferonfactor4-bindinginhumancolorectalitsclinicalEpidemiol.2022Aug;33(2):130-6.EpubJul88.MaHuM,QiY,QiuL,JinY,J,B.Structure-transfectionactivityrelationshipswithconjugatedeliverysystems.Biomaterials.2022年Aug;30(22):3780-9.89.Z,HuangF,XiongH,SunXie

Y.radioresistantcarcinomaactivationtumor-specificpromoter.年28;283(1):20-8.90.FengHuangCG,GuoYW,JiaoBH.BviamediatedmitochondrialpathwayincarcinomaBiolInt.91.Y,SJ,L.InhibitionfarnesylpyrophosphatesynthaseII-inducedresponsesinratneonatalofthekinaseFEBSLett.202217;583(18):2997-3003.92.GS,RenLZ,LinHS,SB,H2O2/HClanddifferentiation.SurgMedOralPatholEndod.2022年93.ZhuJ,JinHanX,YanJ.beta-Ionone-inducedinhuman(U2os)cellsviaasignaling

MolBiol2022年Sep94.Y,J,Y,W,KongLinY,D,NietheandactivitytissueaswellastissuefactorpathwayinhibitorNF-kappaBERK1/2pathway.FEBSLett.20223;583(17):2811-8.Epub年Jul95.WL,QianY,LinYC,YY,SP,LiuJ,PeiZ,WangnovelmarinexyloketalprotectsoxidizedinducedinjuryinBiochem15;78(8):941-50.96.H,LiLvDuanJJ,BianWangLiuYangY,WeiYQ,regulatespolycysticgeneandpromotescellMolBiol2022年97.WangS,LvK,LinX,YuanJ,N.KnockdownofprionexpressionbyinbovinefibroblastMolBiol2022年98.MaHuY,ZouJH,QiuJinY,YingXY,Sun

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論